| Schedule of EPS amounts for all periods and the basic and diluted weighted-average shares outstanding used in the calculation |
| | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | | (In thousands, except per share amounts) | Net income (loss) | | $ | 8,462,545 | | $ | (306,844) | | $ | 8,315,245 | | $ | (510,125) | Less: Net income (loss) attributable to noncontrolling interests, net of tax | | | 173 | | | (712) | | | (242) | | | (1,324) | Net income (loss) attributable to EchoStar - Basic | | | 8,462,372 | | | (306,132) | | | 8,315,487 | | | (508,801) | Interest on dilutive Convertible Notes, net of tax (1) | | | 17,594 | | | — | | | 35,073 | | | — | Net income (loss) attributable to EchoStar - Diluted | | $ | 8,479,966 | | $ | (306,132) | | $ | 8,350,560 | | $ | (508,801) | | | | | | | | | | | | | | Weighted-average common shares outstanding - Class A and B common stock: | | | | | | | | | | | | | Basic | | | 290,141 | | | 287,505 | | | 289,581 | | | 287,012 | Dilutive impact of Convertible Notes (1) | | | 58,007 | | | — | | | 58,007 | | | — | Dilutive impact of stock awards outstanding (1) | | | 3,474 | | | — | | | 3,844 | | | — | Diluted | | | 351,622 | | | 287,505 | | | 351,432 | | | 287,012 | | | | | | | | | | | | | | Earnings per share - Class A and B common stock: | | | | | | | | | | | | | Basic net income (loss) per share attributable to EchoStar | | $ | 29.17 | | $ | (1.06) | | $ | 28.72 | | $ | (1.77) | Diluted net income (loss) per share attributable to EchoStar | | $ | 24.12 | | $ | (1.06) | | $ | 23.76 | | $ | (1.77) |
| (1) | For the three and six months ended June 30, 2025, the interest on dilutive Convertible Notes and the dilutive impact of weighted-average shares of Class A common stock were excluded from the computation of “Diluted net income (loss) per share attributable to EchoStar” because the effect would have been anti-dilutive as a result of the net loss attributable to EchoStar in the period. As of June 30, 2025, our Convertible Notes may be converted into 58 million shares. |
|
| Schedule of anti-dilutive securities not included in the diluted EPS calculation |
| | | | | | | As of June 30, | | | 2026 | | 2025 | | | | (In thousands) | Anti-dilutive stock awards | | 148 | | 3,724 | Performance/market based options | | 4,056 | | 4,257 | Common stock warrants | | 16,151 | | 16,151 | Total | | 20,355 | | 24,132 |
|